According to the World Health Organization (WHO), cervical cancer is the fourth most common malignancy in women worldwide. Each year, there are approximately 528,000 new cases worldwide, resulting in approximately 266,000 deaths. Lymphovascular invasion (LVSI) and lymph node metastasis (LNM) are one of the most important aspects in the evaluation of cervical cancer patients before treatment. In th
Conditions
Interventions
Gold Standard:It was confirmed to be cervical cancer by histopathological examination of the cervical tissue
Index test:Multi-parameter MRI scanning technique
Sponsors
The People’s Hospital of Suzhou New District
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Cervical cancer was confirmed by surgical pathology, and complete surgical pathological results were obtained; 2.Did not receive anti-tumor therapy such as radiotherapy and chemotherapy before surgery; 3.Pelvic MRI plain scan + enhanced scan (T2WI, T1WI, ADC and CE-T1WI) was performed within 2 weeks before surgery.
Exclusion criteria
Exclusion criteria: 1. have had other tumors and received pelvic surgery, radiotherapy or chemotherapy; 2.Incomplete MRI sequence; 3. Poor image quality affects observation and analysis;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The area under the working curve; | — |
Countries
China
Contacts
Public ContactJin Feiqin
The People’s Hospital of Suzhou New District
Outcome results
None listed